Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Consensus Recommendation of “Buy” by Analysts
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has received a consensus recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 month price target […]
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has received a consensus recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 month price target […]
